Literature DB >> 15009290

The risk and risk factors of a second non-melanoma skin cancer: a study in a Mediterranean population.

J Graells1.   

Abstract

BACKGROUND: Non-melanoma skin cancer (NMSC) patients often develop second primary skin tumours. Studies assessing the risk and risk factors on the appearance of a second NMSC are scarce, especially in European countries.
OBJECTIVES: To assess the 5-year risk of a second NMSC in a Mediterranean population, and to find patient characteristics predicting second tumours.
METHODS: NMSC patients at our institution were studied retrospectively. In situ tumours, recurrences, follow-up shorter than 2 months and mucosal lesions were excluded. Data analysed included age, gender, anatomical site, histological subtype, number of tumours and months of follow-up. Disease-free interval was defined as time from histological documentation of the first NMSC to the date of the last follow-up or to the date of histological documentation of the second NMSC. Survival analysis was conducted with the life-table analysis. Cox's proportional hazards regression model was used to assess risk factors.
RESULTS: The study group comprised 535 cases. Of these, 120 patients presented a second NMSC (22.4%). Hazard rates remained high in all yearly intervals. Multivariate analysis showed older age, multiple tumours and male sex as significant prognostic factors. When the second NMSC was diagnosed in the first year of follow-up, a trend to a high risk of further NMSCs was observed.
CONCLUSIONS: The risk of a second NMSC is similar to other studies, although in the lower range. Prognostic factors are also similar to other studies. Yearly hazard rates not falling suggests that long-term follow-up is needed. Prospective studies including whole-body examination could define the exact risk of a second NMSC.

Entities:  

Mesh:

Year:  2004        PMID: 15009290     DOI: 10.1111/j.1468-3083.2004.00893.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.

Authors:  Ulrike Keim; Jolieke C van der Pols; Gail M Williams; Adèle C Green
Journal:  J Invest Dermatol       Date:  2014-09-18       Impact factor: 8.551

2.  Predicting the Risk of a Second Basal Cell Carcinoma.

Authors:  Joris A C Verkouteren; Hilde Smedinga; Ewout W Steyerberg; Albert Hofman; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2015-03-03       Impact factor: 8.551

Review 3.  UV-induced skin cancer at workplace and evidence-based prevention.

Authors:  Birgitta Kütting; Hans Drexler
Journal:  Int Arch Occup Environ Health       Date:  2010-04-23       Impact factor: 3.015

4.  Multiple Basal Cell Carcinomas in Immunocompetent Patients.

Authors:  Paola Savoia; Federica Veronese; Lara Camillo; Vanessa Tarantino; Ottavio Cremona; Elisa Zavattaro
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

5.  Nonmelanoma skin cancer and risk for subsequent malignancy.

Authors:  Jiping Chen; Ingo Ruczinski; Timothy J Jorgensen; Gayane Yenokyan; Yin Yao; Rhoda Alani; Nanette J Liégeois; Sandra C Hoffman; Judith Hoffman-Bolton; Paul T Strickland; Kathy J Helzlsouer; Anthony J Alberg
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

6.  The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma.

Authors:  Jimmy T Efird; Amanda E Toland; C Suzanne Lea; Christopher J Phillips
Journal:  Clin Med Insights Oncol       Date:  2011-03-27

7.  Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years.

Authors:  Wan Hu; Lanlan Fang; Ruyu Ni; Hengchuan Zhang; Guixia Pan
Journal:  BMC Cancer       Date:  2022-07-30       Impact factor: 4.638

8.  Risk Factors and Clinicopathological Features for Developing a Subsequent Primary Cutaneous Squamous and Basal Cell Carcinomas.

Authors:  Magdalena Ciążyńska; Marta Pabianek; Martyna Sławińska; Adam Reich; Bogumił Lewandowski; Katarzyna Szczepaniak; Małgorzata Ułańska; Dariusz Nejc; Robert Brodowski; Michał Sobjanek; Witold Owczarek; Grażyna Kamińska-Winciorek; Dariusz Lange; Monika Słowińska; Katarzyna Wróbel; Andrzej Bieniek; Anna Woźniacka; Anika Pękala; Łukasz Kuncman; Magdalena Salińska; Marcin Noweta; Małgorzata Skibińska; Joanna Narbutt; Karol Ciążyński; Marta Lewandowska; Elżbieta Dziankowska-Zaborszczyk; Aleksandra Lesiak
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.